Radnostix (INIS) Current Deferred Revenue (2018 - 2026)
Radnostix's Current Deferred Revenue came in at $380,810 for Q2 2026, down 33.1% from $568,816 a year earlier and down 35.9% from the prior quarter.
Powered by 
Analysis
Radnostix (INIS) Current Deferred Revenue (2018 - 2026) Analysis & Trends
At the end of FY2025, Radnostix's Current Deferred Revenue was $388,931, down 24.2% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $513,317 in FY2024 (-45.0%), $932,682 in FY2023 (+6.1%), $879,365 in FY2022 (-3.1%) and $907,953 in FY2021 (-21.7%).
- The Q2 2026 figure represents the lowest quarterly Current Deferred Revenue in data going back to Q4 2018.
- Year-over-year, Current Deferred Revenue has declined for nine consecutive quarters, with an average decline of 28.7% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q3 2023 (growth of 10.6%), and the weakest in Q4 2024 (a decline of 45.0%).
- Business Quant data shows INIS's Current Deferred Revenue at $593,948 (Q1 2026), $388,931 (Q4 2025) and $484,568 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Radnostix | 26.09 Mn | 20.19 Mn | 1.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 380,810.00 |
| Mar 31, 2026 | 593,948.00 |
| Dec 31, 2025 | 388,931.00 |
| Sep 30, 2025 | 484,568.00 |
| Jun 30, 2025 | 568,816.00 |
| Mar 31, 2025 | 773,423.00 |
| Dec 31, 2024 | 513,317.00 |
| Sep 30, 2024 | 656,656.00 |
| Jun 30, 2024 | 733,505.00 |
| Mar 31, 2024 | 977,168.00 |
| Dec 31, 2023 | 932,682.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 835,854.00 |
| Mar 31, 2023 | 911,657.00 |
| Dec 31, 2022 | 879,365.00 |
| Sep 30, 2022 | 908,843.00 |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 953,895.00 |
| Dec 31, 2021 | 907,953.00 |
| Sep 30, 2021 | 880,731.00 |
API Access
Radnostix Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();